[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henry H. Ji Ph.D.", "age": 60, "title": "CEO, President & Executive Chairman", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1261651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Ma", "age": 52, "title": "Senior VP, CFO, COO, Corporate Secretary & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 613821, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suketu D. Desai Ph.D.", "age": 59, "title": "Interim Chief Technical Officer & Senior VP", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gigi  DeGuzman", "title": "VP & Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh K. Khemani", "age": 64, "title": "Senior VP, Chief Commercial Officer & GM of Scilex Pharma", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 456820, "exercisedValue": 0, "unexercisedValue": 3799157}, {"maxAge": 1, "name": "Dr. Dmitri V. Lissin M.D.", "age": 65, "title": "Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 528826, "exercisedValue": 0, "unexercisedValue": 3054720}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 20.34, "open": 20.37, "dayLow": 20.0, "dayHigh": 20.9117, "regularMarketPreviousClose": 20.34, "regularMarketOpen": 20.37, "regularMarketDayLow": 20.0, "regularMarketDayHigh": 20.9117, "payoutRatio": 0.0, "beta": 1.357, "forwardPE": -52.20513, "volume": 22059, "regularMarketVolume": 22059, "averageVolume": 213922, "averageVolume10days": 168690, "averageDailyVolume10Day": 168690, "bid": 19.31, "ask": 21.45, "bidSize": 1, "askSize": 1, "marketCap": 124749448, "fiftyTwoWeekLow": 3.6, "fiftyTwoWeekHigh": 34.27, "allTimeHigh": 591.5, "allTimeLow": 3.6, "priceToSalesTrailing12Months": 3.0909178, "fiftyDayAverage": 18.9734, "twoHundredDayAverage": 12.473475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 185106208, "profitMargins": 0.0, "floatShares": 4155474, "sharesOutstanding": 6127183, "sharesShort": 271138, "sharesShortPriorMonth": 279738, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.044299997, "heldPercentInsiders": 0.19654, "heldPercentInstitutions": 0.09916, "shortRatio": 1.88, "shortPercentOfFloat": 0.0585, "impliedSharesOutstanding": 6127183, "bookValue": -29.748, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -375835008, "trailingEps": -40.46, "forwardEps": -0.39, "lastSplitFactor": "1:35", "lastSplitDate": 1744675200, "enterpriseToRevenue": 4.586, "enterpriseToEbitda": -0.714, "52WeekChange": -0.09248942, "SandP52WeekChange": 0.1326145, "quoteType": "EQUITY", "currentPrice": 20.36, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 878000, "totalCashPerShare": 0.148, "ebitda": -259160000, "totalDebt": 67666000, "quickRatio": 0.036, "currentRatio": 0.046, "totalRevenue": 40360000, "revenuePerShare": 4.725, "returnOnAssets": -0.87428004, "grossProfits": 27684000, "freeCashflow": -20055150, "operatingCashflow": 23821000, "revenueGrowth": -0.269, "grossMargins": 0.68593, "ebitdaMargins": 0.0, "operatingMargins": -17.66212, "financialCurrency": "USD", "symbol": "SCLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 20.36, "marketState": "CLOSED", "longName": "Scilex Holding Company", "shortName": "Scilex Holding Company", "priceEpsCurrentYear": -0.6299505, "fiftyDayAverageChange": 1.3866005, "fiftyDayAverageChangePercent": 0.073081285, "twoHundredDayAverageChange": 7.886525, "twoHundredDayAverageChangePercent": 0.63226366, "priceToBook": -0.6844158, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764353050, "regularMarketTime": 1764352798, "exchange": "NCM", "messageBoardId": "finmb_607715156", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0983307, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1614954600000, "postMarketChangePercent": -0.024547806, "postMarketPrice": 20.36, "postMarketChange": -0.0049991608, "regularMarketChange": 0.0200005, "regularMarketDayRange": "20.0 - 20.9117", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 213922, "fiftyTwoWeekLowChange": 16.76, "fiftyTwoWeekLowChangePercent": 4.6555557, "fiftyTwoWeekRange": "3.6 - 34.27", "fiftyTwoWeekHighChange": -13.91, "fiftyTwoWeekHighChangePercent": -0.40589437, "fiftyTwoWeekChangePercent": -9.248942, "earningsTimestampStart": 1763499600, "earningsTimestampEnd": 1763499600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -40.46, "epsForward": -0.39, "epsCurrentYear": -32.32, "displayName": "Scilex Holding", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]